Average annual cost of mAb (same class of therapy) was 96k USD in 2020. 100% of those are covered by insurance providers. The manufacturing process doesn't get cheaper because it's for hairloss, I'm just assuming they will have to take less profits to get people to use it. 20-40k I'd randomly guess.Is there reason to assume this treatment would cost 20k+ per year?
This is why people should be surprised when they see them pursuing other indications, they likely need one of those to succeed to be profitable with this therapy, hairloss could be a financial dud even if it works extremely well.
Last edited: